U.S. Wireless Cardiac Monitoring Systems Market Size, Share & Trends Analysis Report By Test Type (Resting ECG, Stress ECG), By Product Type, By Indication, By End Use (Hospitals & Clinics, Ambulatory / Diagnostic Centers), By Payer Type, And Segment Forecasts, 2026 - 2033
The U.S. wireless cardiac monitoring systems market size was estimated at USD 2.4 billion in 2025 and is projected to reach USD 5.2 billion by 2033, growing at a CAGR of 10.1% from 2026 to 2033. The market is driven by expanding reimbursement coverage for extended ECG and remote monitoring, rising prevalence of cardiac rhythm disorders, and growing adoption of AI-enabled wearable and patch-based technologies that enhance diagnostic accuracy and efficiency.
The shift toward outpatient and home-based monitoring, supported by telehealth integration and payer-backed remote patient management programs, is further accelerating market growth across hospitals, ambulatory centers, and home care settings.
U.S. Wireless Cardiac Monitoring Systems Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wireless cardiac monitoring systems market report based on test type, product type, indication, payer type and end use:
The shift toward outpatient and home-based monitoring, supported by telehealth integration and payer-backed remote patient management programs, is further accelerating market growth across hospitals, ambulatory centers, and home care settings.
U.S. Wireless Cardiac Monitoring Systems Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. wireless cardiac monitoring systems market report based on test type, product type, indication, payer type and end use:
- Test Type Outlook (Revenue, USD Million, 2021 - 2033)
- Resting ECG
- Stress ECG
- Holter Monitoring
- By Monitoring Duration:
- Short-term (24-48 hours)
- Intermediate (3-7 days)
- Long-term (>7 days)
- By Data Handling:
- On-device storage
- Cloud upload
- By Interpretation:
- Manual read
- Automated
- AI-assisted
- Event Monitoring
- By Use Model:
- Intermittent (patient-triggered)
- Continuous (auto-triggered)
- By Data Handling:
- Offline Upload
- Real-time transmission
- By Interpretation:
- Manual
- Automated
- Mobile Cardiac Telemetry (MCT)
- By Monitoring Duration:
- Intermediate (48 hr-7 days)
- Long-term (>7 days)
- By Interpretation:
- Manual confirm
- AI- assisted (primary read)
- Remote/Continuous ECG Monitoring
- By Monitoring Duration:
- Long-term (>14 days)
- Continuous
- By Interpretation:
- Fully AI-assisted
- Physician-validated
- Product Type Outlook (Revenue, USD Million, 2021 - 2033)
- Implantable Cardiac Monitors (ICM)
- By Type / Longevity:
- Insertable Loop Recorders (ILRs)
- Long-life ICMs (>3 years)
- Patch-Type Monitors
- By Lead Configuration:
- Single-lead
- Multi-lead (3-12 leads)
- By Usage:
- Single-use
- Reusable
- Mobile Cardiac Telemetry (MCT)
- By Service Model:
- Patch + Service Bundles
- Module + Subscription
- Holter Device
- By Channel Configuration
- Single-channel
- Multi-channel (3-12 channels)
- Wearable Consumer Devices/ Smartwatches
- By Regulatory Status
- FDA-cleared medical-grade
- Consumer-grade
- Others
- Indication Outlook (Revenue, USD Million, 2021 - 2033)
- Coronary artery disease
- Angina pectoris
- Atherosclerosis
- Heart failure
- Stroke / Transient Ischemic Attack (TIA)
- Others
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Hospitals & Clinics
- Ambulatory / Diagnostic Centers
- Telehealth Providers
- Home Care Settings
- Cardiac Rehabilitation Programs
- Others
- Payer Type Outlook (Revenue, USD Million, 2021 - 2033)
- Medicare
- Medicaid
- Private Insurance
CHAPTER 1. METHODOLOGY AND SCOPE
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. Product Type
1.2.3. Indication
1.2.4. End Use
1.2.5. Payer Type
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.7.3. Three pillars of market estimation
1.7.4. Market modeling & forecasting
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test type outlook
2.2.2. Product type outlook
2.2.3. Indication outlook
2.2.4. End use outlook
2.2.5. Payer type outlook
2.3. Competitive Insights
CHAPTER 3. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Reimbursement and payor support expansion
3.2.1.2. Shift toward value-based care models
3.2.1.3. Advancement in wireless and ai-driven monitoring technologies
3.2.1.4. Integration across cardiac monitoring ecosystems
3.2.2. Market restraint analysis
3.2.2.1. Data integration and interoperability limitations
3.2.2.2. High operational and service costs for long-term monitoring
3.2.3. Market opportunity analysis
3.2.3.1. Expansion of home-based and remote patient monitoring programs
3.2.3.2. Adoption of wireless cardiac monitoring in non-traditional care settings
3.2.3.3. Growing demand due to aging population and rising chronic cardiovascular diseases
3.2.4. Market challenge analysis
3.2.4.1. Regulatory and reimbursement uncertainty for new technologies
3.2.4.2. Limited patient adherence and engagement with long-term monitoring devices
3.3. Industry Trends
3.3.1. Integration of ai and predictive analytics in cardiac monitoring
3.3.2. Shift toward wearable, patch-based, and patient-centric devices
3.3.3. Expansion of cloud-connected remote cardiac care platforms
3.3.4. Partnerships between device makers and telehealth providers
3.3.5. Growing emphasis on data security and regulatory compliance
3.4. U.S. Wireless Cardiac Monitoring Systems Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.5. Case Study Analysis
3.6. Regulatory Framework for U.S. Wireless Cardiac Monitoring Systems Market
3.7. Overview of Competitor Business Models
3.8. High-Level Market Trends Regarding Adoption of Different Business Models
3.9. Pricing, Reimbursement & Procurement Analysis
CHAPTER 4. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET SEGMENT ANALYSIS, BY TEST TYPE (REVENUE IN USD MILLION; 2021 - 2033)
4.1. Definition and Scope
4.2. Test Type Market Share Analysis, 2025 & 2033
4.3. Segment Dashboard
4.4. U.S. Peripheral Vascular Devices and Accessories Market, by Test Type, 2021 to 2033 (USD Million)
4.5. Resting ECG
4.5.1. Resting ECG market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Stress ECG
4.6.1. Stress ECG market estimates and forecasts 2021 to 2033 (USD Million)
4.7. Holter Monitoring
4.7.1. Holter monitoring market estimates and forecasts 2021 to 2033 (USD Million)
4.7.2. By monitoring duration
4.7.2.1. Short-term (24-48 HR)
4.7.2.1.1. Short-term (24-48 HR) market estimates and forecasts 2021 to 2033 (USD Million)
4.7.2.2. Intermediate (3-7 Days)
4.7.2.2.1. Intermediate (3-7 days) market estimates and forecasts 2021 to 2033 (USD Million)
4.7.2.3. Long-Term (>7 Days)
4.7.2.3.1. Long-term (>7 days) market estimates and forecasts 2021 to 2033 (USD Million)
4.7.3. By data handling
4.7.3.1. On-Device Storage
4.7.3.1.1. On-device storage market estimates and forecasts 2021 to 2033 (USD Million)
4.7.3.2. Cloud Upload
4.7.3.2.1. Cloud upload market estimates and forecasts 2021 to 2033 (USD Million)
4.7.4. By Interpretation
4.7.4.1. Manual read
4.7.4.1.1. Manual read market estimates and forecasts 2021 to 2033 (USD Million)
4.7.4.2. Automated
4.7.4.2.1. Automated market estimates and forecasts 2021 to 2033 (USD Million)
4.7.4.3. AI-assisted
4.7.4.3.1. AI-assisted market estimates and forecasts 2021 to 2033 (USD Million)
4.8. Event Monitoring
4.8.1. Event monitoring market estimates and forecasts 2021 to 2033 (USD Million)
4.8.2. By use model
4.8.2.1. Intermittent (patient-triggered)
4.8.2.1.1. Intermittent (patient-triggered) market estimates and forecasts 2021 to 2033 (USD Million)
4.8.2.2. Continuous (auto-trigger)
4.8.2.2.1. Continuous (auto-trigger) market estimates and forecasts 2021 to 2033 (USD Million)
4.8.3. By data handling
4.8.3.1. Offline upload
4.8.3.1.1. Offline upload market estimates and forecasts 2021 to 2033 (USD Million)
4.8.3.2. Real-time transmission
4.8.3.2.1. Real-time transmission market estimates and forecasts 2021 to 2033 (USD Million)
4.8.4. By Interpretation
4.8.4.1. Manual read
4.8.4.1.1. Manual read market estimates and forecasts 2021 to 2033 (USD Million)
4.8.4.2. Automated
4.8.4.2.1. Automated market estimates and forecasts 2021 to 2033 (USD Million)
4.9. Mobile Cardiac Telemetry (MCT)
4.9.1. Mobile Cardiac Telemetry (MCT) market estimates and forecasts 2021 to 2033 (USD Million)
4.9.2. By monitoring duration
4.9.2.1. Intermediate (48 hr-7 days)
4.9.2.1.1. Intermediate (48 hr-7 days) market estimates and forecasts 2021 to 2033 (USD Million)
4.9.2.2. Long-term (>7 days)
4.9.2.2.1. Long-term (>7 days) market estimates and forecasts 2021 to 2033 (USD Million)
4.9.3. By interpretation
4.9.3.1. Manual confirm
4.9.3.1.1. Manual confirm market estimates and forecasts 2021 to 2033 (USD Million)
4.9.3.2. AI-assisted (primary read)
4.9.3.2.1. AI-assisted (primary read) market estimates and forecasts 2021 to 2033 (USD Million)
4.10. Remote/continuous ECG monitoring
4.10.1. Remote/continuous ECG monitoring market estimates and forecasts 2021 to 2033 (USD Million)
4.10.2. By monitoring duration
4.10.2.1. Long-term (>14 days)
4.10.2.1.1. Long-term (>14 days) market estimates and forecasts 2021 to 2033 (USD Million)
4.10.2.2. Continuous (RPM-integrated)
4.10.2.2.1. Continuous (RPM-integrated) market estimates and forecasts 2021 to 2033 (USD Million)
4.10.3. By interpretation
4.10.3.1. Fully AI-assisted
4.10.3.1.1. Fully AI-assisted market estimates and forecasts 2021 to 2033 (USD Million)
4.10.3.2. Physician-validated
4.10.3.2.1. Physician-validated market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 5. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET SEGMENT ANALYSIS, BY PRODUCT TYPE (REVENUE IN USD MILLION; 2021 - 2033)
5.1. Definition and Scope
5.2. Product Type Market Share Analysis, 2025 & 2033
5.3. Segment Dashboard
5.4. U.S. Peripheral Vascular Devices and Accessories Market, by Product Type, 2021 to 2033 (USD Million)
5.5. Implantable Cardiac Monitors
5.5.1. Implantable cardiac monitors market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. By type / longevity
5.5.2.1. Insertable loop recorders (?3 years)
5.5.2.1.1. Insertable loop recorders (?3 years) market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2.2. Long-life ICMS (>3 years)
5.5.2.2.1. Long-life ICMS (>3 years) market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Patch Monitors
5.6.1. Patch monitors market estimates and forecasts 2021 to 2033 (USD Million)
5.6.2. By lead configuration
5.6.2.1. Single-lead
5.6.2.1.1. Single-lead market estimates and forecasts 2021 to 2033 (USD Million)
5.6.2.2. Multi-lead (3-12 leads)
5.6.2.2.1. Multi-lead (3-12 leads) market estimates and forecasts 2021 to 2033 (USD Million)
5.6.3. By usage
5.6.3.1. Single-use
5.6.3.1.1. Single-use market estimates and forecasts 2021 to 2033 (USD Million)
5.6.3.2. Reusable
5.6.3.2.1. Reusable market estimates and forecasts 2021 to 2033 (USD Million)
5.7. MCT Systems
5.7.1. MCT Systems market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2. By service model
5.7.2.1. Patch + service bundles
5.7.2.1.1. Patch + service bundles market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2.2. Module + Subscription
5.7.2.2.1. Module + subscription market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Holter Devices
5.8.1. Holter devices market estimates and forecasts 2021 to 2033 (USD Million)
5.8.2. By channel configuration
5.8.2.1. Single-channel
5.8.2.1.1. Single-channel market estimates and forecasts 2021 to 2033 (USD Million)
5.8.2.2. Multi-Channel (3-12 Channels)
5.8.2.2.1. Multi-channel (3-12 channels) market estimates and forecasts 2021 to 2033 (USD Million)
5.9. Wearable Consumer Devices/ Smartwatches
5.9.1. Wearable consumer devices/ smartwatches market estimates and forecasts 2021 to 2033 (USD Million)
5.9.2. By Regulatory Status
5.9.2.1. FDA Cleared Medical Grade
5.9.2.1.1. FDA cleared medical grade market estimates and forecasts 2021 to 2033 (USD Million)
5.9.2.2. Consumer grade
5.9.2.2.1. Consumer grade market estimates and forecasts 2021 to 2033 (USD Million)
5.10. Others
5.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 6. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET: INDICATION ESTIMATES & TREND ANALYSIS
6.1. Definition and Scope
6.2. Indication Market Share Analysis, 2025 & 2033
6.3. Segment Dashboard
6.4. U.S. Peripheral Vascular Devices and Accessories Market, by Indication, 2021 to 2033 (USD Million)
6.5. Stroke / Transient Ischemic Attack (TIA)
6.5.1. Stroke / Transient Ischemic Attack (TIA) market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Heart Failure
6.6.1. Heart failure market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Coronary Artery Disease (CAD)
6.7.1. Coronary Artery Disease (CAD) market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Angina Pectoris
6.8.1. Angina pectoris market estimates and forecasts 2021 to 2033 (USD Million)
6.9. Atherosclerosis
6.9.1. Atherosclerosis market estimates and forecasts 2021 to 2033 (USD Million)
6.10. Others
6.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 7. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2025 & 2033
7.3. Segment Dashboard
7.4. U.S. Peripheral Vascular Devices and Accessories Market, by End Use, 2021 to 2033 (USD Million)
7.5. Hospitals And Clinics
7.5.1. Hospitals and clinics market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Ambulatory And Diagnostic Centers
7.6.1. Ambulatory and diagnostic centers market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Telehealth Providers
7.7.1. Telehealth providers market estimates and forecasts 2021 to 2033 (USD Million)
7.8. Home Care Settings
7.8.1. Home care settings market estimates and forecasts 2021 to 2033 (USD Million)
7.9. Cardiac Rehabilitation Programs
7.9.1. Cardiac rehabilitation programs market estimates and forecasts 2021 to 2033 (USD Million)
7.10. Others
7.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 8. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET: PAYER ESTIMATES & TREND ANALYSIS
8.1. Definition and Scope
8.2. Payer Market Share Analysis, 2025 & 2033
8.3. Segment Dashboard
8.4. U.S. Peripheral Vascular Devices and Accessories Market, by Payer, 2021 to 2033 (USD Million)
8.5. Medicare
8.5.1. Medicare market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Medicaid
8.6.1. Medicaid market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Private insurance
8.7.1. Private insurance market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization (Key innovators, market leaders, emerging players)
9.3. Company Market Position Analysis, 2025
9.4. Company Profiles
9.4.1. Koninklijke Philips N.V.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. iRhythm Technologies, Inc.
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Abbott
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Medtronic
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Biotronik (Teleflex)
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Boston Scientific Corporation
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Asahi Kasei Corporation
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Avertix Medical, Inc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Baxter
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. OSI Systems, Inc.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. VivaQuant, Inc.
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. Rhythm Express
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Test Type
1.2.2. Product Type
1.2.3. Indication
1.2.4. End Use
1.2.5. Payer Type
1.2.6. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
1.4.1. Purchased database
1.4.2. GVR’s internal database
1.4.3. Secondary sources
1.4.4. Primary research
1.5. Information or Data Analysis
1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
1.7.1. Commodity flow analysis (Model 1)
1.7.2. Volume price analysis (Model 2)
1.7.3. Three pillars of market estimation
1.7.4. Market modeling & forecasting
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives
CHAPTER 2. EXECUTIVE SUMMARY
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Test type outlook
2.2.2. Product type outlook
2.2.3. Indication outlook
2.2.4. End use outlook
2.2.5. Payer type outlook
2.3. Competitive Insights
CHAPTER 3. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET VARIABLES, TRENDS & SCOPE
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.1.1. Reimbursement and payor support expansion
3.2.1.2. Shift toward value-based care models
3.2.1.3. Advancement in wireless and ai-driven monitoring technologies
3.2.1.4. Integration across cardiac monitoring ecosystems
3.2.2. Market restraint analysis
3.2.2.1. Data integration and interoperability limitations
3.2.2.2. High operational and service costs for long-term monitoring
3.2.3. Market opportunity analysis
3.2.3.1. Expansion of home-based and remote patient monitoring programs
3.2.3.2. Adoption of wireless cardiac monitoring in non-traditional care settings
3.2.3.3. Growing demand due to aging population and rising chronic cardiovascular diseases
3.2.4. Market challenge analysis
3.2.4.1. Regulatory and reimbursement uncertainty for new technologies
3.2.4.2. Limited patient adherence and engagement with long-term monitoring devices
3.3. Industry Trends
3.3.1. Integration of ai and predictive analytics in cardiac monitoring
3.3.2. Shift toward wearable, patch-based, and patient-centric devices
3.3.3. Expansion of cloud-connected remote cardiac care platforms
3.3.4. Partnerships between device makers and telehealth providers
3.3.5. Growing emphasis on data security and regulatory compliance
3.4. U.S. Wireless Cardiac Monitoring Systems Market Analysis Tools
3.4.1. Industry Analysis - Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic landscape
3.5. Case Study Analysis
3.6. Regulatory Framework for U.S. Wireless Cardiac Monitoring Systems Market
3.7. Overview of Competitor Business Models
3.8. High-Level Market Trends Regarding Adoption of Different Business Models
3.9. Pricing, Reimbursement & Procurement Analysis
CHAPTER 4. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET SEGMENT ANALYSIS, BY TEST TYPE (REVENUE IN USD MILLION; 2021 - 2033)
4.1. Definition and Scope
4.2. Test Type Market Share Analysis, 2025 & 2033
4.3. Segment Dashboard
4.4. U.S. Peripheral Vascular Devices and Accessories Market, by Test Type, 2021 to 2033 (USD Million)
4.5. Resting ECG
4.5.1. Resting ECG market estimates and forecasts 2021 to 2033 (USD Million)
4.6. Stress ECG
4.6.1. Stress ECG market estimates and forecasts 2021 to 2033 (USD Million)
4.7. Holter Monitoring
4.7.1. Holter monitoring market estimates and forecasts 2021 to 2033 (USD Million)
4.7.2. By monitoring duration
4.7.2.1. Short-term (24-48 HR)
4.7.2.1.1. Short-term (24-48 HR) market estimates and forecasts 2021 to 2033 (USD Million)
4.7.2.2. Intermediate (3-7 Days)
4.7.2.2.1. Intermediate (3-7 days) market estimates and forecasts 2021 to 2033 (USD Million)
4.7.2.3. Long-Term (>7 Days)
4.7.2.3.1. Long-term (>7 days) market estimates and forecasts 2021 to 2033 (USD Million)
4.7.3. By data handling
4.7.3.1. On-Device Storage
4.7.3.1.1. On-device storage market estimates and forecasts 2021 to 2033 (USD Million)
4.7.3.2. Cloud Upload
4.7.3.2.1. Cloud upload market estimates and forecasts 2021 to 2033 (USD Million)
4.7.4. By Interpretation
4.7.4.1. Manual read
4.7.4.1.1. Manual read market estimates and forecasts 2021 to 2033 (USD Million)
4.7.4.2. Automated
4.7.4.2.1. Automated market estimates and forecasts 2021 to 2033 (USD Million)
4.7.4.3. AI-assisted
4.7.4.3.1. AI-assisted market estimates and forecasts 2021 to 2033 (USD Million)
4.8. Event Monitoring
4.8.1. Event monitoring market estimates and forecasts 2021 to 2033 (USD Million)
4.8.2. By use model
4.8.2.1. Intermittent (patient-triggered)
4.8.2.1.1. Intermittent (patient-triggered) market estimates and forecasts 2021 to 2033 (USD Million)
4.8.2.2. Continuous (auto-trigger)
4.8.2.2.1. Continuous (auto-trigger) market estimates and forecasts 2021 to 2033 (USD Million)
4.8.3. By data handling
4.8.3.1. Offline upload
4.8.3.1.1. Offline upload market estimates and forecasts 2021 to 2033 (USD Million)
4.8.3.2. Real-time transmission
4.8.3.2.1. Real-time transmission market estimates and forecasts 2021 to 2033 (USD Million)
4.8.4. By Interpretation
4.8.4.1. Manual read
4.8.4.1.1. Manual read market estimates and forecasts 2021 to 2033 (USD Million)
4.8.4.2. Automated
4.8.4.2.1. Automated market estimates and forecasts 2021 to 2033 (USD Million)
4.9. Mobile Cardiac Telemetry (MCT)
4.9.1. Mobile Cardiac Telemetry (MCT) market estimates and forecasts 2021 to 2033 (USD Million)
4.9.2. By monitoring duration
4.9.2.1. Intermediate (48 hr-7 days)
4.9.2.1.1. Intermediate (48 hr-7 days) market estimates and forecasts 2021 to 2033 (USD Million)
4.9.2.2. Long-term (>7 days)
4.9.2.2.1. Long-term (>7 days) market estimates and forecasts 2021 to 2033 (USD Million)
4.9.3. By interpretation
4.9.3.1. Manual confirm
4.9.3.1.1. Manual confirm market estimates and forecasts 2021 to 2033 (USD Million)
4.9.3.2. AI-assisted (primary read)
4.9.3.2.1. AI-assisted (primary read) market estimates and forecasts 2021 to 2033 (USD Million)
4.10. Remote/continuous ECG monitoring
4.10.1. Remote/continuous ECG monitoring market estimates and forecasts 2021 to 2033 (USD Million)
4.10.2. By monitoring duration
4.10.2.1. Long-term (>14 days)
4.10.2.1.1. Long-term (>14 days) market estimates and forecasts 2021 to 2033 (USD Million)
4.10.2.2. Continuous (RPM-integrated)
4.10.2.2.1. Continuous (RPM-integrated) market estimates and forecasts 2021 to 2033 (USD Million)
4.10.3. By interpretation
4.10.3.1. Fully AI-assisted
4.10.3.1.1. Fully AI-assisted market estimates and forecasts 2021 to 2033 (USD Million)
4.10.3.2. Physician-validated
4.10.3.2.1. Physician-validated market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 5. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET SEGMENT ANALYSIS, BY PRODUCT TYPE (REVENUE IN USD MILLION; 2021 - 2033)
5.1. Definition and Scope
5.2. Product Type Market Share Analysis, 2025 & 2033
5.3. Segment Dashboard
5.4. U.S. Peripheral Vascular Devices and Accessories Market, by Product Type, 2021 to 2033 (USD Million)
5.5. Implantable Cardiac Monitors
5.5.1. Implantable cardiac monitors market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2. By type / longevity
5.5.2.1. Insertable loop recorders (?3 years)
5.5.2.1.1. Insertable loop recorders (?3 years) market estimates and forecasts 2021 to 2033 (USD Million)
5.5.2.2. Long-life ICMS (>3 years)
5.5.2.2.1. Long-life ICMS (>3 years) market estimates and forecasts 2021 to 2033 (USD Million)
5.6. Patch Monitors
5.6.1. Patch monitors market estimates and forecasts 2021 to 2033 (USD Million)
5.6.2. By lead configuration
5.6.2.1. Single-lead
5.6.2.1.1. Single-lead market estimates and forecasts 2021 to 2033 (USD Million)
5.6.2.2. Multi-lead (3-12 leads)
5.6.2.2.1. Multi-lead (3-12 leads) market estimates and forecasts 2021 to 2033 (USD Million)
5.6.3. By usage
5.6.3.1. Single-use
5.6.3.1.1. Single-use market estimates and forecasts 2021 to 2033 (USD Million)
5.6.3.2. Reusable
5.6.3.2.1. Reusable market estimates and forecasts 2021 to 2033 (USD Million)
5.7. MCT Systems
5.7.1. MCT Systems market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2. By service model
5.7.2.1. Patch + service bundles
5.7.2.1.1. Patch + service bundles market estimates and forecasts 2021 to 2033 (USD Million)
5.7.2.2. Module + Subscription
5.7.2.2.1. Module + subscription market estimates and forecasts 2021 to 2033 (USD Million)
5.8. Holter Devices
5.8.1. Holter devices market estimates and forecasts 2021 to 2033 (USD Million)
5.8.2. By channel configuration
5.8.2.1. Single-channel
5.8.2.1.1. Single-channel market estimates and forecasts 2021 to 2033 (USD Million)
5.8.2.2. Multi-Channel (3-12 Channels)
5.8.2.2.1. Multi-channel (3-12 channels) market estimates and forecasts 2021 to 2033 (USD Million)
5.9. Wearable Consumer Devices/ Smartwatches
5.9.1. Wearable consumer devices/ smartwatches market estimates and forecasts 2021 to 2033 (USD Million)
5.9.2. By Regulatory Status
5.9.2.1. FDA Cleared Medical Grade
5.9.2.1.1. FDA cleared medical grade market estimates and forecasts 2021 to 2033 (USD Million)
5.9.2.2. Consumer grade
5.9.2.2.1. Consumer grade market estimates and forecasts 2021 to 2033 (USD Million)
5.10. Others
5.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 6. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET: INDICATION ESTIMATES & TREND ANALYSIS
6.1. Definition and Scope
6.2. Indication Market Share Analysis, 2025 & 2033
6.3. Segment Dashboard
6.4. U.S. Peripheral Vascular Devices and Accessories Market, by Indication, 2021 to 2033 (USD Million)
6.5. Stroke / Transient Ischemic Attack (TIA)
6.5.1. Stroke / Transient Ischemic Attack (TIA) market estimates and forecasts 2021 to 2033 (USD Million)
6.6. Heart Failure
6.6.1. Heart failure market estimates and forecasts 2021 to 2033 (USD Million)
6.7. Coronary Artery Disease (CAD)
6.7.1. Coronary Artery Disease (CAD) market estimates and forecasts 2021 to 2033 (USD Million)
6.8. Angina Pectoris
6.8.1. Angina pectoris market estimates and forecasts 2021 to 2033 (USD Million)
6.9. Atherosclerosis
6.9.1. Atherosclerosis market estimates and forecasts 2021 to 2033 (USD Million)
6.10. Others
6.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 7. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET: END USE ESTIMATES & TREND ANALYSIS
7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2025 & 2033
7.3. Segment Dashboard
7.4. U.S. Peripheral Vascular Devices and Accessories Market, by End Use, 2021 to 2033 (USD Million)
7.5. Hospitals And Clinics
7.5.1. Hospitals and clinics market estimates and forecasts 2021 to 2033 (USD Million)
7.6. Ambulatory And Diagnostic Centers
7.6.1. Ambulatory and diagnostic centers market estimates and forecasts 2021 to 2033 (USD Million)
7.7. Telehealth Providers
7.7.1. Telehealth providers market estimates and forecasts 2021 to 2033 (USD Million)
7.8. Home Care Settings
7.8.1. Home care settings market estimates and forecasts 2021 to 2033 (USD Million)
7.9. Cardiac Rehabilitation Programs
7.9.1. Cardiac rehabilitation programs market estimates and forecasts 2021 to 2033 (USD Million)
7.10. Others
7.10.1. Others market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 8. U.S. WIRELESS CARDIAC MONITORING SYSTEMS MARKET: PAYER ESTIMATES & TREND ANALYSIS
8.1. Definition and Scope
8.2. Payer Market Share Analysis, 2025 & 2033
8.3. Segment Dashboard
8.4. U.S. Peripheral Vascular Devices and Accessories Market, by Payer, 2021 to 2033 (USD Million)
8.5. Medicare
8.5.1. Medicare market estimates and forecasts 2021 to 2033 (USD Million)
8.6. Medicaid
8.6.1. Medicaid market estimates and forecasts 2021 to 2033 (USD Million)
8.7. Private insurance
8.7.1. Private insurance market estimates and forecasts 2021 to 2033 (USD Million)
CHAPTER 9. COMPETITIVE LANDSCAPE
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Company/Competition Categorization (Key innovators, market leaders, emerging players)
9.3. Company Market Position Analysis, 2025
9.4. Company Profiles
9.4.1. Koninklijke Philips N.V.
9.4.1.1. Company overview
9.4.1.2. Financial performance
9.4.1.3. Product benchmarking
9.4.1.4. Strategic initiatives
9.4.2. iRhythm Technologies, Inc.
9.4.2.1. Company overview
9.4.2.2. Financial performance
9.4.2.3. Product benchmarking
9.4.2.4. Strategic initiatives
9.4.3. Abbott
9.4.3.1. Company overview
9.4.3.2. Financial performance
9.4.3.3. Product benchmarking
9.4.3.4. Strategic initiatives
9.4.4. Medtronic
9.4.4.1. Company overview
9.4.4.2. Financial performance
9.4.4.3. Product benchmarking
9.4.4.4. Strategic initiatives
9.4.5. Biotronik (Teleflex)
9.4.5.1. Company overview
9.4.5.2. Financial performance
9.4.5.3. Product benchmarking
9.4.5.4. Strategic initiatives
9.4.6. Boston Scientific Corporation
9.4.6.1. Company overview
9.4.6.2. Financial performance
9.4.6.3. Product benchmarking
9.4.6.4. Strategic initiatives
9.4.7. Asahi Kasei Corporation
9.4.7.1. Company overview
9.4.7.2. Financial performance
9.4.7.3. Product benchmarking
9.4.7.4. Strategic initiatives
9.4.8. Avertix Medical, Inc.
9.4.8.1. Company overview
9.4.8.2. Financial performance
9.4.8.3. Product benchmarking
9.4.8.4. Strategic initiatives
9.4.9. Baxter
9.4.9.1. Company overview
9.4.9.2. Financial performance
9.4.9.3. Product benchmarking
9.4.9.4. Strategic initiatives
9.4.10. OSI Systems, Inc.
9.4.10.1. Company overview
9.4.10.2. Financial performance
9.4.10.3. Product benchmarking
9.4.10.4. Strategic initiatives
9.4.11. VivaQuant, Inc.
9.4.11.1. Company overview
9.4.11.2. Financial performance
9.4.11.3. Product benchmarking
9.4.11.4. Strategic initiatives
9.4.12. Rhythm Express
9.4.12.1. Company overview
9.4.12.2. Financial performance
9.4.12.3. Product benchmarking
9.4.12.4. Strategic initiatives
LIST OF TABLES
Table 1 List of Abbreviations
Table 2 U.S. wireless cardiac monitoring systems market, by test type, 2021 - 2033 (USD Million)
Table 3 U.S. wireless cardiac monitoring systems market, by product type, 2021 - 2033 (USD Million)
Table 4 U.S. wireless cardiac monitoring systems market, by indication, 2021 - 2033 (USD Million)
Table 5 U.S. wireless cardiac monitoring systems market, by end use, 2021 - 2033 (USD Million)
Table 6 U.S. wireless cardiac monitoring systems market, by payer type, 2021 - 2033 (USD Million)
Table 1 List of Abbreviations
Table 2 U.S. wireless cardiac monitoring systems market, by test type, 2021 - 2033 (USD Million)
Table 3 U.S. wireless cardiac monitoring systems market, by product type, 2021 - 2033 (USD Million)
Table 4 U.S. wireless cardiac monitoring systems market, by indication, 2021 - 2033 (USD Million)
Table 5 U.S. wireless cardiac monitoring systems market, by end use, 2021 - 2033 (USD Million)
Table 6 U.S. wireless cardiac monitoring systems market, by payer type, 2021 - 2033 (USD Million)
LIST OF FIGURES
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 U.S. wireless cardiac monitoring systems market segmentation
Fig. 8 Market snapshot, 2025
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 U.S. wireless cardiac monitoring systems market: Test type outlook key takeaways
Fig. 15 U.S. wireless cardiac monitoring systems market: Test type movement analysis
Fig. 16 Resting ECG market, 2021 - 2033 (USD Million)
Fig. 17 Stress ECG market, 2021 - 2033 (USD Million)
Fig. 18 Holter monitoring market, 2021 - 2033 (USD Million)
Fig. 19 By monitoring duration market, 2021 - 2033 (USD Million)
Fig. 20 Short-term (24-48 hours) market, 2021 - 2033 (USD Million)
Fig. 21 Intermediate (2-7 days) market, 2021 - 2033 (USD Million)
Fig. 22 Long-term (>7 days) market, 2021 - 2033 (USD Million)
Fig. 23 By data handling market, 2021 - 2033 (USD Million)
Fig. 24 On-device storage market, 2021 - 2033 (USD Million)
Fig. 25 Cloud upload market, 2021 - 2033 (USD Million)
Fig. 26 By interpretation market, 2021 - 2033 (USD Million)
Fig. 27 Manual read market, 2021 - 2033 (USD Million)
Fig. 28 Automated market, 2021 - 2033 (USD Million)
Fig. 29 AI-assisted market, 2021 - 2033 (USD Million)
Fig. 30 Event monitoring market, 2021 - 2033 (USD Million)
Fig. 31 By use model market, 2021 - 2033 (USD Million)
Fig. 32 Intermittent (patient-triggered) market, 2021 - 2033 (USD Million)
Fig. 33 Continuous (auto-triggered) market, 2021 - 2033 (USD Million)
Fig. 34 By data handling market, 2021 - 2033 (USD Million)
Fig. 35 Offline upload market, 2021 - 2033 (USD Million)
Fig. 36 Real-time transmission market, 2021 - 2033 (USD Million)
Fig. 37 By Interpretation market, 2021 - 2033 (USD Million)
Fig. 38 Manual market, 2021 - 2033 (USD Million)
Fig. 39 Automated market, 2021 - 2033 (USD Million)
Fig. 40 Mobile Cardiac Telemetry (MCT) market, 2021 - 2033 (USD Million)
Fig. 41 By monitoring duration market, 2021 - 2033 (USD Million)
Fig. 42 Intermediate (48 hr-7 days) market, 2021 - 2033 (USD Million)
Fig. 43 Long-term (>7 days) market, 2021 - 2033 (USD Million)
Fig. 44 By Interpretation market, 2021 - 2033 (USD Million)
Fig. 45 Manual confirm market, 2021 - 2033 (USD Million)
Fig. 46 AI- assisted (primary read) market, 2021 - 2033 (USD Million)
Fig. 47 Remote/continuous ECG monitoring market, 2021 - 2033 (USD Million)
Fig. 48 By monitoring duration market, 2021 - 2033 (USD Million)
Fig. 49 Long-term (>14 days) market, 2021 - 2033 (USD Million)
Fig. 50 Continuous market, 2021 - 2033 (USD Million)
Fig. 51 By interpretation market, 2021 - 2033 (USD Million)
Fig. 52 Fully AI-assisted market, 2021 - 2033 (USD Million)
Fig. 53 Physician-validated market, 2021 - 2033 (USD Million)
Fig. 54 U.S. wireless cardiac monitoring systems market: Product type outlook key takeaways
Fig. 55 U.S. wireless cardiac monitoring systems market: Product type movement analysis
Fig. 56 Implantable Cardiac Monitors (ICM) market, 2021 - 2033 (USD Million)
Fig. 57 By Type / Longevity market, 2021 - 2033 (USD Million)
Fig. 58 Insertable Loop Recorders (ILRs) market, 2021 - 2033 (USD Million)
Fig. 59 Long-life ICMs (>3 years) market, 2021 - 2033 (USD Million)
Fig. 60 Patch-type monitors market, 2021 - 2033 (USD Million)
Fig. 61 By lead configuration market, 2021 - 2033 (USD Million)
Fig. 62 Single-lead market, 2021 - 2033 (USD Million)
Fig. 63 Multi-lead (3-12 leads) market, 2021 - 2033 (USD Million)
Fig. 64 By usage market, 2021 - 2033 (USD Million)
Fig. 65 Single-use market, 2021 - 2033 (USD Million)
Fig. 66 Reusable market, 2021 - 2033 (USD Million)
Fig. 67 Mobile Cardiac Telemetry (MCT) market, 2021 - 2033 (USD Million)
Fig. 68 By service model market, 2021 - 2033 (USD Million)
Fig. 69 Patch + service bundles market, 2021 - 2033 (USD Million)
Fig. 70 Module + subscription market, 2021 - 2033 (USD Million)
Fig. 71 Wearable consumer devices / smartwatches market, 2021 - 2033 (USD Million)
Fig. 72 By regulatory status market, 2021 - 2033 (USD Million)
Fig. 73 FDA-cleared market, 2021 - 2033 (USD Million)
Fig. 74 Clinical-grade market, 2021 - 2033 (USD Million)
Fig. 75 Consumer-grade market, 2021 - 2033 (USD Million)
Fig. 76 By channel configuration market, 2021 - 2033 (USD Million)
Fig. 77 Single-channel market, 2021 - 2033 (USD Million)
Fig. 78 Multi-channel (3-12 channels) market, 2021 - 2033 (USD Million)
Fig. 79 Others market, 2021 - 2033 (USD Million)
Fig. 80 U.S. wireless cardiac monitoring systems market: Indication outlook key takeaways
Fig. 81 U.S. wireless cardiac monitoring systems market: Indication movement analysis
Fig. 82 Coronary Artery Disease (CAD) market, 2021 - 2033 (USD Million)
Fig. 83 Angina pectoris market, 2021 - 2033 (USD Million)
Fig. 84 Atherosclerosis market, 2021 - 2033 (USD Million)
Fig. 85 Heart failure market, 2021 - 2033 (USD Million)
Fig. 86 Stroke / TIA monitoring market, 2021 - 2033 (USD Million)
Fig. 87 Others market, 2021 - 2033 (USD Million)
Fig. 88 U.S. wireless cardiac monitoring systems market: End use outlook key takeaways
Fig. 89 U.S. wireless cardiac monitoring systems market: End use movement analysis
Fig. 90 Hospitals & clinics market, 2021 - 2033 (USD Million)
Fig. 91 Ambulatory / diagnostic centers market, 2021 - 2033 (USD Million)
Fig. 92 Telehealth providers / remote patient monitoring programs market, 2021 - 2033 (USD Million)
Fig. 93 Home Care / Self-monitoring market, 2021 - 2033 (USD Million)
Fig. 94 Cardiac Rehabilitation Programs & Post-acute care providers market, 2021 - 2033 (USD Million)
Fig. 95 Others market, 2021 - 2033 (USD Million)
Fig. 96 U.S. wireless cardiac monitoring systems market: Payer type outlook key takeaways
Fig. 97 U.S. wireless cardiac monitoring systems market: Payer type movement analysis
Fig. 98 Medicare market, 2021 - 2033 (USD Million)
Fig. 99 Medicaid market, 2021 - 2033 (USD Million)
Fig. 100 Private Insurance market, 2021 - 2033 (USD Million)
Fig. 101 Strategy framework
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 U.S. wireless cardiac monitoring systems market segmentation
Fig. 8 Market snapshot, 2025
Fig. 9 Market trends & outlook
Fig. 10 Market driver relevance analysis (current & future impact)
Fig. 11 Market restraint relevance analysis (current & future impact)
Fig. 12 Swot analysis, by factor (political & legal, economic and technological)
Fig. 13 Porter’s five forces analysis
Fig. 14 U.S. wireless cardiac monitoring systems market: Test type outlook key takeaways
Fig. 15 U.S. wireless cardiac monitoring systems market: Test type movement analysis
Fig. 16 Resting ECG market, 2021 - 2033 (USD Million)
Fig. 17 Stress ECG market, 2021 - 2033 (USD Million)
Fig. 18 Holter monitoring market, 2021 - 2033 (USD Million)
Fig. 19 By monitoring duration market, 2021 - 2033 (USD Million)
Fig. 20 Short-term (24-48 hours) market, 2021 - 2033 (USD Million)
Fig. 21 Intermediate (2-7 days) market, 2021 - 2033 (USD Million)
Fig. 22 Long-term (>7 days) market, 2021 - 2033 (USD Million)
Fig. 23 By data handling market, 2021 - 2033 (USD Million)
Fig. 24 On-device storage market, 2021 - 2033 (USD Million)
Fig. 25 Cloud upload market, 2021 - 2033 (USD Million)
Fig. 26 By interpretation market, 2021 - 2033 (USD Million)
Fig. 27 Manual read market, 2021 - 2033 (USD Million)
Fig. 28 Automated market, 2021 - 2033 (USD Million)
Fig. 29 AI-assisted market, 2021 - 2033 (USD Million)
Fig. 30 Event monitoring market, 2021 - 2033 (USD Million)
Fig. 31 By use model market, 2021 - 2033 (USD Million)
Fig. 32 Intermittent (patient-triggered) market, 2021 - 2033 (USD Million)
Fig. 33 Continuous (auto-triggered) market, 2021 - 2033 (USD Million)
Fig. 34 By data handling market, 2021 - 2033 (USD Million)
Fig. 35 Offline upload market, 2021 - 2033 (USD Million)
Fig. 36 Real-time transmission market, 2021 - 2033 (USD Million)
Fig. 37 By Interpretation market, 2021 - 2033 (USD Million)
Fig. 38 Manual market, 2021 - 2033 (USD Million)
Fig. 39 Automated market, 2021 - 2033 (USD Million)
Fig. 40 Mobile Cardiac Telemetry (MCT) market, 2021 - 2033 (USD Million)
Fig. 41 By monitoring duration market, 2021 - 2033 (USD Million)
Fig. 42 Intermediate (48 hr-7 days) market, 2021 - 2033 (USD Million)
Fig. 43 Long-term (>7 days) market, 2021 - 2033 (USD Million)
Fig. 44 By Interpretation market, 2021 - 2033 (USD Million)
Fig. 45 Manual confirm market, 2021 - 2033 (USD Million)
Fig. 46 AI- assisted (primary read) market, 2021 - 2033 (USD Million)
Fig. 47 Remote/continuous ECG monitoring market, 2021 - 2033 (USD Million)
Fig. 48 By monitoring duration market, 2021 - 2033 (USD Million)
Fig. 49 Long-term (>14 days) market, 2021 - 2033 (USD Million)
Fig. 50 Continuous market, 2021 - 2033 (USD Million)
Fig. 51 By interpretation market, 2021 - 2033 (USD Million)
Fig. 52 Fully AI-assisted market, 2021 - 2033 (USD Million)
Fig. 53 Physician-validated market, 2021 - 2033 (USD Million)
Fig. 54 U.S. wireless cardiac monitoring systems market: Product type outlook key takeaways
Fig. 55 U.S. wireless cardiac monitoring systems market: Product type movement analysis
Fig. 56 Implantable Cardiac Monitors (ICM) market, 2021 - 2033 (USD Million)
Fig. 57 By Type / Longevity market, 2021 - 2033 (USD Million)
Fig. 58 Insertable Loop Recorders (ILRs) market, 2021 - 2033 (USD Million)
Fig. 59 Long-life ICMs (>3 years) market, 2021 - 2033 (USD Million)
Fig. 60 Patch-type monitors market, 2021 - 2033 (USD Million)
Fig. 61 By lead configuration market, 2021 - 2033 (USD Million)
Fig. 62 Single-lead market, 2021 - 2033 (USD Million)
Fig. 63 Multi-lead (3-12 leads) market, 2021 - 2033 (USD Million)
Fig. 64 By usage market, 2021 - 2033 (USD Million)
Fig. 65 Single-use market, 2021 - 2033 (USD Million)
Fig. 66 Reusable market, 2021 - 2033 (USD Million)
Fig. 67 Mobile Cardiac Telemetry (MCT) market, 2021 - 2033 (USD Million)
Fig. 68 By service model market, 2021 - 2033 (USD Million)
Fig. 69 Patch + service bundles market, 2021 - 2033 (USD Million)
Fig. 70 Module + subscription market, 2021 - 2033 (USD Million)
Fig. 71 Wearable consumer devices / smartwatches market, 2021 - 2033 (USD Million)
Fig. 72 By regulatory status market, 2021 - 2033 (USD Million)
Fig. 73 FDA-cleared market, 2021 - 2033 (USD Million)
Fig. 74 Clinical-grade market, 2021 - 2033 (USD Million)
Fig. 75 Consumer-grade market, 2021 - 2033 (USD Million)
Fig. 76 By channel configuration market, 2021 - 2033 (USD Million)
Fig. 77 Single-channel market, 2021 - 2033 (USD Million)
Fig. 78 Multi-channel (3-12 channels) market, 2021 - 2033 (USD Million)
Fig. 79 Others market, 2021 - 2033 (USD Million)
Fig. 80 U.S. wireless cardiac monitoring systems market: Indication outlook key takeaways
Fig. 81 U.S. wireless cardiac monitoring systems market: Indication movement analysis
Fig. 82 Coronary Artery Disease (CAD) market, 2021 - 2033 (USD Million)
Fig. 83 Angina pectoris market, 2021 - 2033 (USD Million)
Fig. 84 Atherosclerosis market, 2021 - 2033 (USD Million)
Fig. 85 Heart failure market, 2021 - 2033 (USD Million)
Fig. 86 Stroke / TIA monitoring market, 2021 - 2033 (USD Million)
Fig. 87 Others market, 2021 - 2033 (USD Million)
Fig. 88 U.S. wireless cardiac monitoring systems market: End use outlook key takeaways
Fig. 89 U.S. wireless cardiac monitoring systems market: End use movement analysis
Fig. 90 Hospitals & clinics market, 2021 - 2033 (USD Million)
Fig. 91 Ambulatory / diagnostic centers market, 2021 - 2033 (USD Million)
Fig. 92 Telehealth providers / remote patient monitoring programs market, 2021 - 2033 (USD Million)
Fig. 93 Home Care / Self-monitoring market, 2021 - 2033 (USD Million)
Fig. 94 Cardiac Rehabilitation Programs & Post-acute care providers market, 2021 - 2033 (USD Million)
Fig. 95 Others market, 2021 - 2033 (USD Million)
Fig. 96 U.S. wireless cardiac monitoring systems market: Payer type outlook key takeaways
Fig. 97 U.S. wireless cardiac monitoring systems market: Payer type movement analysis
Fig. 98 Medicare market, 2021 - 2033 (USD Million)
Fig. 99 Medicaid market, 2021 - 2033 (USD Million)
Fig. 100 Private Insurance market, 2021 - 2033 (USD Million)
Fig. 101 Strategy framework
